Chief Executive Officer at Optimal Acuity Corporation - Princeton, New Jersey, United States
Developing Corneal Photovitrification (CPV) treatments to improve vision lost to blinding diseases of the eye. (The Clear-K (R) Treatment has not been evaluated by the FDA and is not available in the USA)